AGA
Altrinsic Global Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-170,000
| Closed | -$5.31M | – | 71 |
|
|
2021
Q4 | $5.31M | Hold |
170,000
| – | – | 0.17% | 47 |
|
|
2021
Q3 | $2.6M | Hold |
170,000
| – | – | 0.08% | 60 |
|
|
2021
Q2 | $3.17M | Hold |
170,000
| – | – | 0.1% | 56 |
|
|
2021
Q1 | $3.04M | Hold |
170,000
| – | – | 0.1% | 56 |
|
|
2020
Q4 | $2.62M | Hold |
170,000
| – | – | 0.09% | 53 |
|
|
2020
Q3 | $1.88M | Hold |
170,000
| – | – | 0.08% | 55 |
|
|
2020
Q2 | $2.13M | Hold |
170,000
| – | – | 0.09% | 54 |
|
|
2020
Q1 | $1.93M | Sell |
170,000
-10,000
| -6% | -$113K | 0.11% | 51 |
|
|
2019
Q4 | $2.36M | Hold |
180,000
| – | – | 0.1% | 51 |
|
|
2019
Q3 | $1.62M | Hold |
180,000
| – | – | 0.07% | 57 |
|
|
2019
Q2 | $1.78M | Buy |
180,000
+20,000
| +13% | +$197K | 0.08% | 59 |
|
|
2019
Q1 | $1.63M | Buy |
160,000
+10,000
| +7% | +$102K | 0.08% | 64 |
|
|
2018
Q4 | $947K | Buy |
150,000
+30,000
| +25% | +$189K | 0.05% | 67 |
|
|
2018
Q3 | $1.58M | Buy |
+120,000
| New | +$1.58M | 0.07% | 67 |
|